Quick Answer
VYNE Therapeutics Inc. reported Total Assets of $30.16 million for fiscal year 2025.
VYNE Therapeutics Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $30.16M | -54.9% |
| 2024 | $66.91M | -31.5% |
| 2023 | $97.69M | +139.7% |
| 2022 | $40.76M | -39.2% |
| 2021 | $67.05M | -28.5% |
| 2020 | $93.74M | +15.5% |
| 2019 | $81.16M | -42.0% |
| 2018 | $139.93M | +109.3% |
| 2017 | $66.87M | +59.0% |
| 2016 | $42.05M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| June 30, 2025 | $44.72M | -48.4% | -20.7% |
| March 31, 2025 | $56.42M | -38.5% | -15.7% |
| December 31, 2024 | $66.91M | -31.5% | -12.2% |
| September 30, 2024 | $76.20M | +295.5% | -12.1% |
| June 30, 2024 | $86.65M | +247.2% | -5.5% |
| March 31, 2024 | $91.68M | +160.0% | -6.2% |
| December 31, 2023 | $97.69M | +139.7% | +407.0% |
| September 30, 2023 | $19.27M | -58.9% | -22.8% |
- VYNE Therapeutics Inc. showed a decrease of -54.9% in Total Assets compared to the prior fiscal year.
- Over the 2016–2025 period, VYNE Therapeutics Inc.’s total assets has declined by 28.3% (from $42.05 million to $30.16 million).
- The most recent figure is from VYNE Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: